| Attribute |
Value |
| 52 Week Change |
0.14705884 |
| Address1 |
301 Carnegie Center Drive |
| Address2 |
Suite 304 |
| All Time High |
128,125.0 |
| All Time Low |
2.0 |
| Ask |
8.35 |
| Ask Size |
2 |
| Average Analyst Rating |
1.3 - Strong Buy |
| Average Daily Volume10 Day |
19,170 |
| Average Daily Volume3 Month |
62,823 |
| Average Volume |
62,823 |
| Average Volume10Days |
19,170 |
| Beta |
-0.012 |
| Bid |
9.45 |
| Bid Size |
5 |
| Book Value |
3.758 |
| City |
Princeton |
| Compensation As Of Epoch Date |
1,798,675,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
7.83 |
| Current Ratio |
4.608 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
8.375 |
| Day Low |
7.8 |
| Debt To Equity |
3.345 |
| Display Name |
Palatin |
| Dividend Yield |
0.0 |
| Ebitda |
-8,605,609 |
| Ebitda Margins |
-0.65268 |
| Enterprise To Ebitda |
-0.85 |
| Enterprise To Revenue |
0.555 |
| Enterprise Value |
7,317,629 |
| Eps Current Year |
-2.41 |
| Eps Forward |
-1.855 |
| Eps Trailing Twelve Months |
-2.96 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
10.0226 |
| Fifty Day Average Change |
-2.1926003 |
| Fifty Day Average Change Percent |
-0.21876562 |
| Fifty Two Week Change Percent |
14.705885 |
| Fifty Two Week High |
31.0 |
| Fifty Two Week High Change |
-23.17 |
| Fifty Two Week High Change Percent |
-0.74741936 |
| Fifty Two Week Low |
5.61 |
| Fifty Two Week Low Change |
2.2199998 |
| Fifty Two Week Low Change Percent |
0.39572188 |
| Fifty Two Week Range |
5.61 - 31.0 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
876,922,200,000 |
| Float Shares |
1,489,043 |
| Forward Eps |
-1.855 |
| Forward P E |
-4.221024 |
| Free Cashflow |
-10,665,235 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
25 |
| Fullday Change |
-0.35999966 |
| Fullday Change Percent |
-4.3956003 |
| Fullday Price |
7.83 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0619 |
| Gross Profits |
816,158 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.081099994 |
| Held Percent Institutions |
0.50109 |
| Implied Shares Outstanding |
1,780,939 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Language |
en-US |
| Last Fiscal Year End |
1,782,777,600 |
| Last Split Date |
1,754,956,800 |
| Last Split Factor |
1:50 |
| Long Business Summary |
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity completed Phase 2 clinical trial; completed a phase 2 of diabetic nephropathy It also provides pl9643 for dry eye disease; and oral PL8177 for inflammatory bowel diseases. licensing arrangements and other strategic transactions to advance and maximize the value of certain product candidates and program for the treatment of retinal diseases and with Altanispac Labs for PL9643 for the treatment of dry eye disease; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Princeton, New Jersey. |
| Long Name |
Palatin Technologies, Inc. |
| Market |
us_market |
| Market Cap |
13,944,752 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_32651 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-8,377,895 |
| Next Fiscal Year End |
1,814,313,600 |
| Non Diluted Market Cap |
18,273,154 |
| Number Of Analyst Opinions |
3 |
| Open |
8.01 |
| Operating Cashflow |
-13,533,270 |
| Operating Margins |
-14.69495 |
| Payout Ratio |
0.0 |
| Peg Ratio |
1.62 |
| Phone |
609 495 2200 |
| Previous Close |
8.19 |
| Price Eps Current Year |
-3.2489624 |
| Price Hint |
2 |
| Price To Book |
2.0835552 |
| Price To Sales Trailing12 Months |
1.0576199 |
| Profit Margins |
-0.63541 |
| Quick Ratio |
4.398 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.33333 |
| Region |
US |
| Regular Market Change |
-0.35999966 |
| Regular Market Change Percent |
-4.3956003 |
| Regular Market Day High |
8.375 |
| Regular Market Day Low |
7.8 |
| Regular Market Day Range |
7.8 - 8.375 |
| Regular Market Open |
8.01 |
| Regular Market Previous Close |
8.19 |
| Regular Market Price |
7.83 |
| Regular Market Time |
1,791,995,356 |
| Regular Market Volume |
19,697 |
| Return On Assets |
-0.91897005 |
| Return On Equity |
-8.775331 |
| Revenue Per Share |
4.664 |
| Sand P52 Week Change |
0.17004645 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
1,780,939 |
| Shares Percent Shares Out |
0.2049 |
| Shares Short |
364,901 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
345,482 |
| Short Name |
Palatin Technologies, Inc. |
| Short Percent Of Float |
0.21540001 |
| Short Ratio |
2.69 |
| Source Interval |
15 |
| State |
NJ |
| Symbol |
PTN |
| Target High Price |
60.0 |
| Target Low Price |
47.5 |
| Target Mean Price |
53.5 |
| Target Median Price |
53.0 |
| Total Cash |
7,492,014 |
| Total Cash Per Share |
4.207 |
| Total Debt |
223,679 |
| Total Revenue |
13,185,031 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-2.96 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
14.74455 |
| Two Hundred Day Average Change |
-6.91455 |
| Two Hundred Day Average Change Percent |
-0.46895632 |
| Type Disp |
Equity |
| Volume |
19,697 |
| Website |
https://palatin.com |
| Zip |
8,540 |